Prevalence of Hearing Loss among Sickle Cell Patients at the Korle-Bu Teaching Hospital

dc.contributor.advisorBoafo, N.
dc.contributor.advisorAsare, G.A.
dc.contributor.authorBoakye-Akuffo, R.
dc.contributor.otherUniversity of Ghana, College of Health Sciences School of Biomedical and Allied Health Sciences Department of Audiology, Speech and Language
dc.date.accessioned2017-04-06T15:11:02Z
dc.date.accessioned2017-10-13T17:58:56Z
dc.date.available2017-04-06T15:11:02Z
dc.date.available2017-10-13T17:58:56Z
dc.date.issued2015-07
dc.descriptionThesis(MSc)-University of Ghana, 2015
dc.description.abstractBackground: Sickle Cell Disease (SCD) is one of the commonest blood and genetic disorders in the world. It results when abnormal haemoglobin (Hb S, Hb C, Hb β-thalassemia) is found either in the homozygous or heterozygote state. Sickle cell disease causes painful vascular occlusion crisis, anoxia and ischaemia which sometimes lead to tissue or organ damage including the auditory system especially the blood rich cochlear. Damage to the auditory system eventually causes hearing loss. Aim: The study assessed the hearing status of the sickle cell disease patients reporting to the Adult Sickle Cell Clinic of the Korle-Bu Teaching hospital. Methods: A case control study involving 100 known genotyped sickle cell patients from the adult SCD Clinic at the Ghana Institute of Clinical Genetics, Korle-Bu Teaching hospital and age-matched 100 confirmed haemoglobin AA genotyped participants (staff and students of School of Biomedical and Allied Health Sciences, University of Ghana) constituted this study. Subjects were selected based on inclusion and exclusion criteria. A structured questionnaire was administered to obtain basic information on socio-demographic parameters and case history of the participants. Their hearing was assessed by pure tone audiometry in a sound treated booth. Results: A significant association between hearing status and hemoglobin genotype for air and bone conduction thresholds was observed. This was evidenced by relatively higher prevalence of hearing loss among participants with Hb SS and Hb SC genotypes (cases) compared to respondents with Hb AA genotype (control) at the respective tested frequencies. Conclusion: There is significant difference in hearing thresholds in persons living with SCD and the control group. Results from this study showed one type of loss (sensorineural hearing loss) among Ghanaian adult SCD patients. Likewise, the degree of hearing loss among the SCD patients ranged from mild to profound from 2000 Hz to 8000 Hz. Finally, sensorineural hearing loss presented more among the Hb SS genotype group than the Hb SC group. Keywords: Sickle cell disease, vascular occlusion, haemoglobin, haemolysis, hearing loss.en_US
dc.format.extentXii, 77p: ill
dc.identifier.urihttp://197.255.68.203/handle/123456789/21940
dc.language.isoenen_US
dc.publisherUniversity of Ghanaen_US
dc.rights.holderUniversity of Ghana
dc.subjectHearing Lossen_US
dc.subjectSickle Cell Patientsen_US
dc.subjectKorle-Bu Teaching Hospitalen_US
dc.titlePrevalence of Hearing Loss among Sickle Cell Patients at the Korle-Bu Teaching Hospitalen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Prevalence of Hearing Loss among Sickle Cell Patients at the Korle-Bu Teaching Hospital_2015.pdf
Size:
5 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: